115 related articles for article (PubMed ID: 2041549)
1. Recovery of motor function after spinal-cord injury--a randomized, placebo-controlled trial with GM-1 ganglioside.
Geisler FH; Dorsey FC; Coleman WP
N Engl J Med; 1991 Jun; 324(26):1829-38. PubMed ID: 2041549
[TBL] [Abstract][Full Text] [Related]
2. Influence of ganglioside combined with methylprednisolone sodium succinate on efficacy and neurological function in patients with acute myelitis.
Sun YF; Liu LL; Jiang SS; Zhang XJ; Liu FJ; Zhang WM
World J Clin Cases; 2023 Nov; 11(33):7972-7979. PubMed ID: 38075571
[TBL] [Abstract][Full Text] [Related]
3. An updated systematic review of neuroprotective agents in the treatment of spinal cord injury.
Serag I; Abouzid M; Elmoghazy A; Sarhan K; Alsaad SA; Mohamed RG
Neurosurg Rev; 2024 Mar; 47(1):132. PubMed ID: 38546884
[TBL] [Abstract][Full Text] [Related]
4. Studying missingness in spinal cord injury data: challenges and impact of data imputation.
Bourguignon L; Lukas LP; Guest JD; Geisler FH; Noonan V; Curt A; Brüningk SC; Jutzeler CR
BMC Med Res Methodol; 2024 Jan; 24(1):5. PubMed ID: 38184529
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor 5 protects against spinal cord injury through activating AMPK pathway.
Chen F; Xiong BR; Xian SY; Zhang J; Ding RW; Xu M; Zhang ZZ
J Cell Mol Med; 2023 Dec; 27(23):3706-3716. PubMed ID: 37950418
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the effect of intrathecal GM1 in 24, 48, and 72 hours after acute spinal cord injury in rats.
Jorge DMF; Marcon RM; Cristante AF; Filho TEPB; Dos Santos GB
Clinics (Sao Paulo); 2023; 78():100228. PubMed ID: 37418797
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological management of acute spinal cord injury: a longitudinal multi-cohort observational study.
Jutzeler CR; Bourguignon L; Tong B; Ronca E; Bailey E; Harel NY; Geisler F; Ferguson AR; Kwon BK; Cragg JJ; Grassner L; Kramer JLK
Sci Rep; 2023 Apr; 13(1):5434. PubMed ID: 37012257
[TBL] [Abstract][Full Text] [Related]
8. A Bibliometric Analysis of Publications on Spinal Cord Injury Treatment With Glucocorticoids Using VOSviewer.
Zhang Y; Li AA; Xiao SN; Zhong NS; Tong WL; Wang SJ; Liu JM; Liu ZL
Front Public Health; 2022; 10():907372. PubMed ID: 36003626
[TBL] [Abstract][Full Text] [Related]
9. Gangliosides in nervous system development, regeneration, and pathologies.
Vasques JF; de Jesus Gonçalves RG; da Silva-Junior AJ; Martins RS; Gubert F; Mendez-Otero R
Neural Regen Res; 2023 Jan; 18(1):81-86. PubMed ID: 35799513
[TBL] [Abstract][Full Text] [Related]
10. Established and Emerging Therapies in Acute Spinal Cord Injury.
Gadot R; Smith DN; Prablek M; Grochmal JK; Fuentes A; Ropper AE
Neurospine; 2022 Jun; 19(2):283-296. PubMed ID: 35793931
[TBL] [Abstract][Full Text] [Related]
11. Progression in translational research on spinal cord injury based on microenvironment imbalance.
Fan B; Wei Z; Feng S
Bone Res; 2022 Apr; 10(1):35. PubMed ID: 35396505
[TBL] [Abstract][Full Text] [Related]
12. Novel insights on GM1 and Parkinson's disease: A critical review.
Fazzari M; Di Biase E; Lunghi G; Mauri L; Chiricozzi E; Sonnino S
Glycoconj J; 2022 Feb; 39(1):27-38. PubMed ID: 35064857
[TBL] [Abstract][Full Text] [Related]
13. Beyond the lesion site: minocycline augments inflammation and anxiety-like behavior following SCI in rats through action on the gut microbiota.
Schmidt EKA; Raposo PJF; Torres-Espin A; Fenrich KK; Fouad K
J Neuroinflammation; 2021 Jun; 18(1):144. PubMed ID: 34174901
[TBL] [Abstract][Full Text] [Related]
14. Ganglioside GM1 Targets Astrocytes to Stimulate Cerebral Energy Metabolism.
Finsterwald C; Dias S; Magistretti PJ; Lengacher S
Front Pharmacol; 2021; 12():653842. PubMed ID: 33995070
[TBL] [Abstract][Full Text] [Related]
15. Acute spinal cord injury: Pathophysiology and pharmacological intervention (Review).
Zhang Y; Al Mamun A; Yuan Y; Lu Q; Xiong J; Yang S; Wu C; Wu Y; Wang J
Mol Med Rep; 2021 Jun; 23(6):. PubMed ID: 33846780
[TBL] [Abstract][Full Text] [Related]
16. Significance of the neurological level of injury as a prognostic predictor for motor complete cervical spinal cord injury patients.
Kawano O; Maeda T; Sakai H; Masuda M; Morishita Y; Hayashi T; Kubota K; Kobayakawa K; Yokota K; Kaneyama H
J Spinal Cord Med; 2023 May; 46(3):494-500. PubMed ID: 33830904
[No Abstract] [Full Text] [Related]
17. Temporal Lobe Necrosis Following Radiotherapy in Nasopharyngeal Carcinoma: New Insight Into the Management.
Zhou X; Liu P; Wang X
Front Oncol; 2020; 10():593487. PubMed ID: 33552967
[TBL] [Abstract][Full Text] [Related]
18. GM1 Oligosaccharide Crosses the Human Blood-Brain Barrier In Vitro by a Paracellular Route.
Di Biase E; Lunghi G; Maggioni M; Fazzari M; Pomè DY; Loberto N; Ciampa MG; Fato P; Mauri L; Sevin E; Gosselet F; Sonnino S; Chiricozzi E
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325905
[TBL] [Abstract][Full Text] [Related]
19. A Review on the Etiology and Management of Pediatric Traumatic Spinal Cord Injuries.
Benmelouka A; Shamseldin LS; Nourelden AZ; Negida A
Adv J Emerg Med; 2020; 4(2):e28. PubMed ID: 32322796
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic repair for spinal cord injury: combinatory approaches to address a multifaceted problem.
Griffin JM; Bradke F
EMBO Mol Med; 2020 Mar; 12(3):e11505. PubMed ID: 32090481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
